Literature DB >> 27719832

Charcot, hysteria, and simulated disorders.

C G Goetz1.   

Abstract

Jean-Martin Charcot (1825-1893) was the 19th-century's premier international neurologist. One of his areas of focused interest was the neurologic disorder, hysteria, a condition with distinctive neurologic signs, but no established structural lesions identified at autopsy. Charcot considered hysteria as a physiologic disorder that affected specific neuroanatomic areas of the brain comparable to the same areas that were damaged by structural neurologic disorders provoking the same or similar signs. He considered hysteria primarily a hereditary disorder, but environmental factors including physical and emotional stress served as provoking factors. Charcot drew the strict distinction between hysteria and consciously simulated neurologic disorders, although he was keenly aware that the two disorders could occur in the same patients or be difficult to distinguish at times. He developed specific experimental techniques to separate hysteria from simulation. His studies of hysteria and simulation offer a basis for studies of functional neurologic disorders applicable to the 21st century.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  19th-century neurologic history; Jean-Martin Charcot; functional neurologic disease; hysteria; psychogenic; simulation

Mesh:

Year:  2016        PMID: 27719832     DOI: 10.1016/B978-0-12-801772-2.00002-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  3 in total

1.  Gender Differences in Functional Movement Disorders.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  Mov Disord Clin Pract       Date:  2019-12-24

2.  Botulinum Neurotoxin Injections in Childhood Opisthotonus.

Authors:  Mariam Hull; Mered Parnes; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-02-12       Impact factor: 4.546

3.  The illness-disease dichotomy and the biological-clinical splitting of medicine.

Authors:  Luigi Tesio; Marco Buzzoni
Journal:  Med Humanit       Date:  2020-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.